For the Inventor, By the Inventor

Enter assignee name

Shire Biochem, Inc.

USPTO Granted Patents = 16

CIPO Patents = 2

EPO Patents = 1

Forward Citations = 129

Loading Chart...

Loading Chart...

41 inventors (with patents filed for the assignee):

Songchun Jiang (3 out of 16 patents)

Giorgio Attardo (3 out of 19 patents)

Nghe Nguyen-Ba (3 out of 28 patents)

4. Sui Xiong Cai (3 out of 87 patents)

5. Qing Yu (3 out of 3 patents)

6. Francis J Giles (3 out of 6 patents)

7. Hong Zhang (2 out of 30 patents)

8. Robert F Rando (2 out of 16 patents)

9. Richard Storer (2 out of 9 patents)

10. Jacques Jolivet (2 out of 2 patents)

11. William E Kemnitzer (2 out of 6 patents)

12. Dragos Vizitiu (1 out of 8 patents)

13. Boulos Zacharie (1 out of 29 patents)

14. Jean-Eric Lacoste (1 out of 5 patents)

15. Serge Lamothe (1 out of 6 patents)

16 patents: Sort by Forward Citations

1. 7528164 - Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof (2009-05-05),

2. 7501514 - Enantiomeric resolution of 2-substituted 4-substituted 1,3-oxathiolanes nucleosides (2009-03-10),

3. 7476741 - Substituted 4H-chromens, 2H-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof (2009-01-13),

4. 7465465 - Pharmaceutical formulation comprising lanthanum compounds (2008-12-16),

5. 7442813 - Process for producing dioxolane nucleoside analogues (2008-10-28),

6. 7230100 - Stereoselective method for the preparation of nucleosides (2007-06-12),

7. 7122693 - Acetaldehyde acetal compounds, their synthesis, and uses thereof (2006-10-17),

8. 7109334 - Stereoselective methods for the preparation of nucleosides (2006-09-19),

9. RE39155 - Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B (2006-07-03),

10. 7015328 - Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof (2006-03-21),

11. 6964968 - Method for the treatment or prevention of viral infection using nucleoside analogues (2005-11-15),

12. 6960594 - Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer (2005-11-01),

13. 6887879 - Pharmaceutical combination of antiviral agents (2005-05-03),

14. 6831174 - Processes for preparing substituted 1, 3-oxathiolanes with antiviral properties (2004-12-14),

15. 6800639 - Pharmaceutical combination for the treatment of cancer (2004-10-05),

Shire BioChem, Inc. is a leading pharmaceutical company specializing in the research, development, and manufacturing of innovative biotechnology products. With a strong focus on improving global health, we strive to deliver high-quality and effective solutions to patients worldwide. Our expertise lies in the areas of biopharmaceuticals, specialty drugs, and therapeutic proteins. At Shire BioChem, we are committed to advancing medical science through cutting-edge research and collaboration with industry partners. Visit our website to learn more about our products and contributions to the healthcare sector.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

16 Patents

#106 in

#891 in Canada

#36,684 in the World

Shire Biochem, Inc.

Forward Citations = 129

41 inventors:

Songchun Jiang (3 out of 16 patents)

Giorgio Attardo (3 out of 19 patents)

Nghe Nguyen-Ba (3 out of 28 patents)

4. Sui Xiong Cai (3 out of 87 patents)

5. Qing Yu (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…